Cartesian Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2020 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Cartesian Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2020 to Q3 2024.
  • Cartesian Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 21.5M shares, a 316% increase year-over-year.
  • Cartesian Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 155M shares, a 7.15% increase from 2022.
  • Cartesian Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 145M shares, a 26.6% increase from 2021.
  • Cartesian Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 114M shares, a 13% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 21.5M +16.3M +316% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 16.7M +11.6M +227% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 5.41M +303K +5.92% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 155M +10.4M +7.15% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-07
Q3 2023 5.16M -148M -96.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 5.11M -143M -96.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 5.11M -119M -95.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 145M +30.4M +26.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-07
Q3 2022 153M +37.7M +32.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 149M +35M +30.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-17
Q1 2022 124M +13.5M +12.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 114M Oct 1, 2021 Dec 31, 2021 10-K 2024-03-07
Q3 2021 115M +9.84M +9.35% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 114M +16.7M +17.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 111M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q3 2020 105M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 96.8M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.